secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001493152-23-034696
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo appoints part-time CFO Daniel George replacing Sandra Gardiner effective Sept 28
--------------------------------------------------------------------------------

- Daniel George appointed part-time CFO, principal financial and accounting officer; replaces Sandra A. Gardiner.
- Compensation at $400/hour; typical schedule up to 10 hours per week, remote from Morgan Hill, CA.
- Mr. George previously CFO of Lucira Health (2020-2022) and runs a consulting practice since Dec 2022.
- Offer letter filed as Exhibit 10.1 includes standard at-will and arbitration provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315223034696/0001493152-23-034696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315223034696/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-034696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer